Xi Tan
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 2
- Extracellular vesicles in disease 2
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Yinghuan Li (5 shared papers)Yuanyuan Ren (4 shared papers)Xiangliang Yang (4 shared papers)Huaguo Chen (2 shared papers)Xuhan Liu (3 shared papers)Lingyan Liu (2 shared papers)Xin Zhou (1 shared paper)Yan Fang (2 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (2 papers)BMC Cardiovascular Disorders (1 paper)Advanced Materials (1 paper)Biochimica et Biophysica Acta (BBA) - Biomembranes (1 paper)Biomaterials (1 paper)
- Partner nations
- ChinaNetherlandsTaiwan
In The Last Decade
Xi Tan
25 papers receiving 410 citations
Peers
Comparison fields: 5 of 86
- Biomaterials 100
- Pharmaceutical Science 23
- Molecular Biology 191
- Cancer Research 26
- Biomedical Engineering 70
Countries citing papers authored by Xi Tan
This map shows the geographic impact of Xi Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Tan more than expected).
Fields of papers citing papers by Xi Tan
This network shows the impact of papers produced by Xi Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Tan. The network helps show where Xi Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 52 | |
| 2 | 2016 | 48 | |
| 3 | 2017 | 27 | |
| 4 | 2017 | 27 | |
| 5 | 2025 | 25 | |
| 6 | 2024 | 23 | |
| 7 | 2023 | 22 | |
| 8 | 2018 | 19 | |
| 9 | 2022 | 18 | |
| 10 | 2016 | 18 | |
| 11 | 2019 | 17 | |
| 12 | 2023 | 16 | |
| 13 | 2014 | 16 | |
| 14 | 2015 | 15 | |
| 15 | 2023 | 12 | |
| 16 | 2020 | 11 | |
| 17 | Role of gut microbiome in ankylosing spondylitis: an analysis of studies in literature. | 2016 | 10 |
| 18 | 2020 | 10 | |
| 19 | 2020 | 9 | |
| 20 | 2020 | 7 |
About Xi Tan
Xi Tan is a scholar working on Molecular Biology, Biomaterials, Oncology, Physiology and Biotechnology, having authored 26 papers that have together received 412 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (2 papers), Extracellular vesicles in disease (2 papers), Cancer Research and Treatments (2 papers), Cancer-related molecular mechanisms research (2 papers), Nanoplatforms for cancer theranostics (2 papers), Marine Sponges and Natural Products (1 paper) and Allergic Rhinitis and Sensitization (1 paper). The work is most often cited by research in Biomaterials (100 citations), Pharmaceutical Science (23 citations), Molecular Biology (191 citations), Cancer Research (26 citations) and Biomedical Engineering (70 citations). Xi Tan has collaborated with scholars based in China, Netherlands and Taiwan. Frequent co-authors include Yinghuan Li, Yuanyuan Ren, Xiangliang Yang, Huaguo Chen, Xuhan Liu, Lingyan Liu, Xin Zhou, Yan Fang, Ming Zhao and Lei Gao. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, BMC Cardiovascular Disorders, Advanced Materials, Biochimica et Biophysica Acta (BBA) - Biomembranes and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.